Danny L. Dearen - Mar 1, 2022 Form 4 Insider Report for Axonics, Inc. (AXNX)

Role
Officer
Signature
/s/ Danny L. Dearen
Stock symbol
AXNX
Transactions as of
Mar 1, 2022
Transactions value $
-$830,374
Form type
4
Date filed
3/3/2022, 06:45 PM
Previous filing
Mar 1, 2022
Next filing
Aug 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Options Exercise $318K +12.3K +43.67% $25.82 40.6K Mar 1, 2022 Direct
transaction AXNX Common Stock Sale -$84.5K -1.5K -3.7% $56.32 39.1K Mar 1, 2022 Direct F1, F2
transaction AXNX Common Stock Sale -$450K -7.85K -20.08% $57.40 31.2K Mar 1, 2022 Direct F1, F3
transaction AXNX Common Stock Sale -$614K -10.6K -33.84% $58.11 20.7K Mar 1, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -12.3K -84.03% $0.00 2.34K Mar 1, 2022 Common Stock 12.3K $25.82 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $55.82 to $56.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $56.84 to $57.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $57.85 to $58.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date.